Aclarion
ACON
10 hedge funds and large institutions have $368K invested in Aclarion in 2026 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
359% more capital invested
Capital invested by funds: $80.2K → $368K (+$288K)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
25% more funds holding
Funds holding: 8 → 10 (+2)
2.34% more ownership
Funds ownership: 2.6% → 4.93% (+2.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$120K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$107K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$34.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$29.4K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$15.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.32K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$33 |
ACON Hedge Fund Activity: Q1 2026 in Review
10 of the 8,127 institutional investors tracked by Wall St. Rank reported a position in Aclarion (ACON) for Q1 2026, worth a combined $368K — up 359% from $80.2K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ACON positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $120K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $4.32K sold.
- 10 institutional investors held Aclarion (ACON) as of Q1 2026, up from 8 in Q4 2025.
- Funds reported $368K of Aclarion stock for Q1 2026, up 359% quarter-over-quarter.
- 4 funds opened new Aclarion positions in Q1 2026 and 2 closed out, a net change of +2 holders.
- The largest Aclarion buyer in Q1 2026 was Osaic Holdings, an estimated $120K added.
- The largest Aclarion seller in Q1 2026 was Tower Research Capital (TRC), an estimated $4.32K sold.
Based on aggregated 13F filings for Q1 2026.